// App-Quantinova.ai

771 : Neuropathology of dopa-responsive dystonia due to Tyrosine hydroxylase deficiency

Researchers

Presenter

  • S. Schreglmann

Principal Investigators

  • Z. Jaunmuktane

  • H. Jung

  • C. Strand

  • J. Holton

  • K. Bhatia

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Segawa syndrome autosomal recessive

  • Dystonia

Biomarkers

  • Alpha-synuclein

  • Glial fibrillary acidic protein

  • Sequestosome-1

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A